GlassScriptPhysician profile
Shimul A Shah
NPI 1811962327
$8,346.70
in general payments reported to CMS, 2019-2025
9 companies · $20.28 in 2025
The $20.28 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,074 · 2021: $22.75 · 2022: $154 · 2023: $3,885 · 2024: $2,191 · 2025: $20.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,165 · Education: $1,500 · Food and Beverage: $825 · Travel and Lodging: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,165.00 |
| Education | $1,500.00 |
| Food and Beverage | $824.85 |
| Travel and Lodging | $605.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $3,281.06 | 2023 | Tecentriq |
| Intuitive Surgical, INC. | $2,146.05 | 2024 | |
| Sirtex Medical INC | $1,750.00 | 2019 | |
| Organ Recovery Systems, INC. | $920.21 | 2019-2024 | |
| Medtronic, INC. | $154.08 | 2022 | |
| Ethicon US, LLC | $39.07 | 2021-2023 | Echelon Flex, Enseal, Prolene |
| Tela Bio, INC. | $24.21 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Organox LTD | $20.28 | 2025 | |
| Angiodynamics, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shimul Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.